The only Food and Drug Administration vaccine advisory panel member to abstain from a major vote this week that essentially authorized Pfizer’s COVID-19 vaccine for children as young as 5 said he did so because of limited safety and efficacy data. All 17 others voted to advise the administration, or the FDA, to authorize the…